These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10462228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC.
    Lancet; 1993 May 01; 341(8853):1129-31. PubMed ID: 8097813
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ.
    BMC Infect Dis; 2014 Jan 07; 14():7. PubMed ID: 24397793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.
    Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S.
    Lancet; 1991 Mar 30; 337(8744):747-50. PubMed ID: 1672389
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug 30; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 9. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.
    Egypt J Immunol; 2014 Aug 30; 21(1):13-26. PubMed ID: 25204041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [Abstract] [Full Text] [Related]

  • 12. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F, Ma YJ, Zhou TY, Duan JC, Wang JF, Ji YL, Li H, Zhang JY, Tang H.
    Viral Immunol; 2016 Aug 16; 29(1):40-8. PubMed ID: 26565951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO, Noubiap JJ, Nansseu JR, Aminde LN, Bigna JJ, Ndze VN, Moyou RS.
    BMC Public Health; 2016 Aug 03; 15():706. PubMed ID: 27487845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A.
    Pediatr Hematol Oncol; 2009 Jun 03; 26(4):195-201. PubMed ID: 19437322
    [Abstract] [Full Text] [Related]

  • 18. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C, Zanchi R, Seck A, Garin B, Giles-Vernick T, Gody JC, Bata P, Pondy A, Tetang SM, Ba M, Ekobo CS, Rousset D, Sire JM, Maylin S, Chartier L, Njouom R, Vray M.
    BMC Infect Dis; 2015 Jul 12; 15():267. PubMed ID: 26164361
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand.
    Poovorawan Y, Theamboonlers A, Hirsch P, Vimolket T, Sinlaparatsamee S, Chaiear K, Siraprapasiri T, Khwanjaipanich S, Owatanapanich S, Chunsuttiwat S.
    Ann Trop Med Parasitol; 2000 Sep 12; 94(6):615-21. PubMed ID: 11064763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.